Paid Lupus Clinical Trial Now Enrolling at Achieve Clinical Research...

Achieve is conducting a phase II, placebo-controlled, multi dose, 24-week clinical study to evaluate the efficacy and safety of a new autoimmune medication in participants living with...(PRWeb March 11, 2014)Read the full story at http://www.prweb.com/releases/2014/03/prweb11643043.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news